Takeda Pharmaceutical Company Limited revised earnings forecast for the Fiscal Year Ending March 31, 2022. For the period, the company revised forecast of Net profit for the year to JPY 184.3 billion against Previous Forecast of JPY 250.0 billion a year ago. revised forecast of EPS to JPY 117.35 billion against Previous Forecast of JPY 159.91 billion a year ago. While Revenue, Operating profit, Profit before tax forecasted to be JPY 3,370.0 billion, JPY 488.0 billion, JPY 352.0 billion respectively. Core Operating Profit forecasted to be JPY 930.0 billion. Core EPS forecasted to be JPY 394.